A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics) in healthy adults
This research is looking into how a new medicine, aticaprant (also known as JNJ-67953964), behaves in the body, specifically how long it stays active. Scientists want to see if taking another medicine called carbamazepine at the same time changes this. This kind of study helps understand how different drugs might interact with each other. It's a very early-stage study, using healthy adult volunteers, which means the main goal is to gather information about how the drug works in the body, rather than testing if it treats a specific illness. This information is really important for developing new medicines safely.
At a glance
What is this study about?
Imagine your body as a processing plant for medicines. When you take a pill, your body breaks it down and gets rid of it over time. This study is like sending a new medicine, called aticaprant (JNJ-67953964), through this plant and watching it closely.
We specifically want to see if another common medicine, carbamazepine, changes how quickly your body processes aticaprant. Think of it like this: if you have two machines working in a factory, does one machine speed up or slow down the other? This is very important because knowing how medicines interact helps doctors prescribe them safely and effectively. It helps make sure you get the right amount of medication at the right time.
This type of study is an early step in developing new medicines. It's called 'Human Pharmacology' because it's all about understanding how the new drug works in the human body, especially how it's absorbed, processed, and cleared out. The results from studies like this help scientists decide the best way to give the medicine in the future and what to watch out for when people take other drugs at the same time. This helps ensure medicines are as safe and effective as possible for everyone.
Key takeaways
- This study investigates how two medicines interact in the body.
- It aims to understand how long the new drug, aticaprant, stays in the system when taken with carbamazepine.
- Only healthy adults are participating.
- It's an early-stage study focused on drug behaviour, not treating a disease.
- Participation involves taking study drugs and having regular health checks.
Who may be eligible?
This study is looking for volunteers who are healthy adults. To take part, you need to be at least 18 years old. There's no upper age limit mentioned, so older adults can also be considered.
Both men and women are welcome to participate in this research. The most important thing is that you are generally healthy and don't have any major ongoing health problems.
Further checks will be carried out to make sure you are suitable for the study. For example, doctors will want to ensure you're not taking any other medicines that might interfere with the study drugs, and they'll check your general health before you can join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally in good health?
- Are you willing to take study medications?
- Are you able to attend multiple clinic visits?
- Are you comfortable with regular blood and urine tests?
What does participation involve?
If you decide to take part, you would receive doses of aticaprant and carbamazepine over a period of time. This would likely involve multiple visits to a clinic or research centre. During these visits, the study team would regularly take blood and urine samples to measure the levels of the drugs in your body. They would also monitor your health closely through various checks, like blood pressure and heart rate measurements, to ensure your safety.
The specific number of visits, how long each visit lasts, and the total duration of your involvement in the study would be explained in full detail by the research team. You would also have a schedule for taking the study medications, which you must follow carefully. After your last dose of medication, there may be follow-up appointments to make sure the drugs have left your system and you are well.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What does 'pharmacokinetics' mean?
It's a science-y word for how a medicine moves through your body: how it's absorbed, distributed, processed, and eventually leaves your system.
Why use healthy adults for this study?
Using healthy adults helps scientists understand how the drug works in a standard body without other illnesses or medications complicating the results.
What is aticaprant / JNJ-67953964?
It's a new medicine currently being researched. This study is an early step to understand how it behaves in the body.
What is carbamazepine?
It's an established medicine used to treat certain conditions like epilepsy and nerve pain. Here, it's used to see how it affects the new drug, aticaprant.
Will this study help me with a specific health problem?
No, this study is about understanding how medicines interact, not about treating a particular illness. It's too early for that.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.